More than 50 million people of all ages suffer from epilepsy, otherwise known as seizure disorder, the fourth most common neurological disease in the world. Patients diagnosed with epilepsy often experience recurrent seizures triggered by the firing of a large collection of neurons in the brain. This ultimately generates a high-energy wave that spreads across the surface of the brain, resulting in numerous physical effects such as erratic body shaking, unconsciousness, exhaustion, and pain.
A study finds that people with uncontrolled epilepsy ? neurological disorder ? resort to cannabis products when antiepileptic drug side-effects are intolerable. Epilepsy is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain. University of Sydney researchers revealed that 14 percent of people with epilepsy have used cannabis products as a way to manage seizures.
A novel statistical approach to analyzing patients with epilepsy has revealed details about their brains’ internal networks. The findings may lead to better understanding and treatment of the disease, according to Rice University researchers.
Republican Virginia Rep. Griffith Morgan introduced HR 715 that could reschedule marijuana which is currently a Schedule I drug. If it passes, marijuana will be rebranded under the Federal Controlled Substance Act. HR 715 also removes Cannabidiol (CBD) oil from the marijuana umbrella and removes restrictions on marijuana research, The Leaf Online reports. There is no word in HR 715 as to how marijuana will be rebranded and this worries Kelly Cronic, a CWU public health major.
Neuronal degeneration is the most severe long-term consequence of repetitive seizures in patients with epilepsy, which until now was thought to be primarily caused by excitotoxicity, or over-stimulation of the neurons. New findings indicate hypoxia, or lack of oxygen, due to abnormal blood flow may be to blame for as much as half the neuronal death caused by the condition.
Prolonged epileptic seizures may cause serious problems that will continue for the rest of a patient’s life. As a result of a seizure, neural connections of the brain may be rewired in an incorrect way. This may result in seizures that are difficult to control with medication. Mechanisms underlying this phenomenon are not entirely known, which makes current therapies ineffective in some patients.
A new study published in Epilepsia found that although most newly diagnosed cases of epilepsy in older adults are treated appropriately with monotherapy, only half of those patients receive treatment within the recommended time frame, and a substantial portion were prescribed older antiepileptic drugs (AEDs) despite recommendations to use newer AEDs in this population.
Epileptic activity appear to be more frequent in patients with Alzheimer’s disease than in healthy individuals and may be linked to disease progression, according to a recent study. These findings, previously seen in animals, suggest that increased neuronal excitability, a feature of epilepsy, may also contribute to the onset and progression of Alzheimer’s disease. Of the study’s patients, as many as 42.4 percent presented subclinical epileptiform spikes, especially during sleep. The study, “Incidence And Impact Of Subclinical Epileptiform Activity In Alzheimer’s Disease,” was published in the journal Annals of Neurology. The exchange of electrical signals in the brain is the basis of neuronal communication and activity. But in epileptic seizures, these signals are propagated in an exagger...
Over the past few years Sodium Channels have been linked to epilepsy and researchers have focused on this area of research to understand genetic epilepsy. A new study by Northwestern Medicine focused on discovering the genetic causes of irregularities in sodium channels and the potential for regulating them. Via Northwestern Medicine: A new Northwestern Medicine study may help explain why patients with the same epilepsy gene mutation experience different levels of disease severity. The findings, published in the Proceedings of the National Academy of Sciences (PNAS), also reveal new insights into sodium channel regulation and a potential therapeutic target for epilepsy treatment. Christopher Thompson, PhD, research assistant professor of Pharmacology, was the first author of the study, led...
Medtronic plc (NYSE: MDT) announced today that the first procedure using the Visualase(TM) MRI-Guided Laser Ablation System has been performed in the pivotal SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) clinical trial at Mayo Clinic in Rochester, Minn.
The American Academy of Neurology (AAN) has released the first evidence-based guideline comparing procedures used for determining brain lateralization prior to epilepsy surgery and for predicting post-surgical language and memory deficits.
Researchers have identified a network of 320 genes in the brain that are linked to epilepsy — a finding that could help address genetic anomalies that lead to the condition. In about 25 percent of cases, epilepsy has a clear cause, such as a head trauma or stroke. But most cases are the result of a genetic anomaly, researchers said in the study “Rare And Common Epilepsies Converge On A Shared Gene Regulatory Network Providing Opportunities For Novel Antiepileptic Drug Discovery.” It was published in the journal Genome Biology.